{
    "2021-03-05": [
        [
            {
                "time": "2021-11-15",
                "original_text": "EMA issues advice on Lilly's bamlanivimab (LY-CoV555) alone and administered together with etesevimab (LY-CoV016) for the treatment of confirmed COVID-19 in the European Union",
                "features": {
                    "keywords": [
                        "EMA",
                        "Lilly",
                        "bamlanivimab",
                        "etesevimab",
                        "COVID-19",
                        "treatment",
                        "European Union"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare",
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            },
            {
                "time": "2021-11-15",
                "original_text": "Loxo Oncology at Lilly Announces Publication of Pirtobrutinib (LOXO-305) Phase 1/2 Data in The Lancet",
                "features": {
                    "keywords": [
                        "Loxo Oncology",
                        "Lilly",
                        "Pirtobrutinib",
                        "LOXO-305",
                        "Phase 1/2",
                        "The Lancet"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare",
                        "biotechnology"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            }
        ]
    ]
}